We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$821B
AUM Growth
+$62.3B
Cap. Flow
+$23.5B
Cap. Flow %
2.87%
Top 10 Hldgs %
16.79%
Holding
7,579
New
751
Increased
3,314
Reduced
2,056
Closed
652
Avg Time Held Equity + Options
17.5 quarters
Top 10 Avg Time Held Equity + Options
16.2 quarters
Top 20 Avg Time Held Equity + Options
12.2 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
16.2 quarters
Top 20 Avg Time Held Equity only
14.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.28%
2 Technology 17.17%
3 Healthcare 10.79%
4 Financials 9.36%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HOLX
6676
CALL
DELISTED
Hologic
HOLX
– –
-175,500
Closed -$13.1M –
HOLX
6677
PUT
DELISTED
Hologic
HOLX
– –
-74,200
Closed -$5.55M –
HOOK
6678
DELISTED
HOOKIPA Pharma
HOOK
$0 ﹤0.01%
1
– –
2019 Q2
15 quarters
HQL
6679
abrdn Life Sciences Investors
HQL
$538M
$0 ﹤0.01%
2
+1
+100% +$14
2022 Q4
1 quarter
HRL icon
6680
CALL
Hormel Foods
HRL
$11.1B
– –
-90,000
Closed -$4.1M –
HRL icon
6681
PUT
Hormel Foods
HRL
$11.1B
– –
-90,000
Closed -$4.1M –
STRR
6682
Star Equity Holdings
STRR
$36M
$0 ﹤0.01%
+21
New +$512
2023 Q1
0 quarters
HSY icon
6683
PUT
Hershey
HSY
$32.2B
– –
-1,200
Closed -$278K –
HYLS icon
6684
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.57B
– –
-38,229
Closed -$1.49M –
IAF
6685
abrdn Australia Equity Fund
IAF
$119M
– –
0
– –
2023 Q1
0 quarters
IAK icon
6686
iShares US Insurance ETF
IAK
$426M
– –
-123
Closed -$11K –
IBIO icon
6687
iBio
IBIO
$72.7M
$0 ﹤0.01%
3
– –
2020 Q2
11 quarters
IBN icon
6688
PUT
ICICI Bank
IBN
$98.5B
– –
-300
Closed -$7K –
IDA icon
6689
CALL
Idacorp
IDA
$7.68B
– –
-2,200
Closed -$237K –
IDN icon
6690
Intellicheck
IDN
$46M
$0 ﹤0.01%
27
– –
2020 Q2
11 quarters
IEMG icon
6691
PUT
iShares Core MSCI Emerging Markets ETF
IEMG
$163B
– –
-300,000
Closed -$16.3M –
IEUS icon
6692
iShares MSCI Europe Small-Cap ETF
IEUS
$171M
– –
-50
Closed -$2K –
IFN
6693
Aberdeen India Fund
IFN
$454M
$0 ﹤0.01%
+8
New +$124
2023 Q1
0 quarters
IFV icon
6694
First Trust Dorsey Wright International Focus 5 ETF
IFV
$218M
– –
-6
Closed – –
IHDG icon
6695
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.09B
– –
-145
Closed -$5K –
INCR
6696
Intercure
INCR
$81.3M
$0 ﹤0.01%
20
-672
-97% -$10.1K
2022 Q1
4 quarters
INDL icon
6697
Direxion Daily MSCI India Bull 2X ETF
INDL
$49M
– –
-87
Closed -$4K –
INFU icon
6698
InfuSystem Holdings
INFU
$262M
$0 ﹤0.01%
26
– –
2020 Q2
11 quarters
INKM icon
6699
State Street Income Allocation ETF
INKM
$77.3M
– –
-268
Closed -$8K –
INZY
6700
DELISTED
Inozyme Pharma
INZY
$0 ﹤0.01%
60
– –
2020 Q3
10 quarters

Similar funds

JP Morgan Chase's Q1 2023 Portfolio in Review

As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
  • JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
  • JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
  • JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
  • JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.